For the Inventor, By the Inventor

Enter assignee name

The Woodlands, TX, United States of America

Lexicon Genetics Corporation

USPTO Granted Patents = 102

% Expired Patents = 62.7

Trademarks = 1

Forward Citations = 243

Loading Chart...

Loading Chart...

50 inventors (with patents filed for the assignee):

C Alexander Turner, Jr (56 out of 59 patents)

Brian Zambrowicz (44 out of 50 patents)

Arthur T Sands (42 out of 48 patents)

4. Glenn A Friedrich (41 out of 54 patents)

5. Gregory Donoho (31 out of 33 patents)

6. D Wade Walke (26 out of 28 patents)

7. Carl Johan Friddle (22 out of 23 patents)

8. John Scoville (22 out of 22 patents)

9. Brian Mathur (18 out of 18 patents)

10. Yi Hu (17 out of 20 patents)

11. Michael C Nehls (17 out of 18 patents)

12. Erin Hilbun (15 out of 16 patents)

13. Alejandro Abuin (11 out of 12 patents)

14. Xuanchuan Yu (9 out of 9 patents)

15. Nathaniel L Wilganowski (8 out of 11 patents)

Core Competencies:

Human Kinases

Polynucleotides

Proteins

Gene Disruptions

Gene Mutagenesis

Human Proteases

Human Transferases

Human GABA Receptors

Human Ion Channels

Human Secreted Proteins

Human Semaphorin

Human Thrombospondin

102 patents: Sort by Forward Citations

1. 8227661 - Methods of identifying agents that ameliorate or modulate effects of PRO1328 gene disruptions (2012-07-24),

2. 7252990 - Human dectin proteins and polynucleotides encoding the same (2007-08-07),

3. 7199221 - Human semaphorin homologs and polynucleotides encoding the same (2007-04-03),

4. 7179827 - Thiazoles and methods of their use (2007-02-20),

5. 7144730 - Lipoxygenase proteins and polynucleotides encoding the same (2006-12-05),

6. 7105325 - Human hydroxylases and polynucleotides encoding the same (2006-09-12),

7. 7074591 - Polynucleotides encoding human GABA receptors (2006-07-11),

8. 7057029 - Human ion-exchanger proteins (2006-06-06),

9. 7001763 - Human semaphorin proteins and polynucleotides encoding the same (2006-02-21),

10. 6994995 - Human synaptotagmin and polynucleotides encoding the same (2006-02-07),

11. 6987178 - Human uncoupling proteins and polynucleotides encoding the same (2006-01-17),

12. 6929937 - Human transferase proteins and polynucleotides encoding the same (2005-08-16),

13. 6919192 - Human kinases and polynucleotides encoding the same (2005-07-19),

14. 6908758 - Human kinase proteins and polynucleotides encoding the same (2005-06-21),

15. 6902924 - Human kinases and polynucleotides encoding the same (2005-06-07),

Company Overview

Lexicon Genetics Corporation, based in The Woodlands, TX, specializes in the development of innovative therapeutics through its expertise in human kinases and related biological pathways. The company focuses on advancing drug discovery and development by leveraging its core technologies in polynucleotides, proteins, and gene manipulation techniques such as gene disruptions and mutagenesis. Lexicon's research is pivotal in understanding human proteases, transferases, and GABA receptors, contributing to advancements in various therapeutic areas.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

102 Patents

#6 in The Woodlands, TX

#206 in Texas

#3,725 in US

#7,654 in the World

The Woodlands, TX, United States of America

Lexicon Genetics Corporation

Forward Citations = 243

50 inventors:

C Alexander Turner, Jr (56 out of 59 patents)

Brian Zambrowicz (44 out of 50 patents)

Arthur T Sands (42 out of 48 patents)

4. Glenn A Friedrich (41 out of 54 patents)

5. Gregory Donoho (31 out of 33 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lexicon Genetics Corporation. Retrieved from https://idiyas.com/company/lexicon-genetics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…